Delving into the Latest Updates on Theron Pharmaceuticals, Inc. with Synapse

概览

关联

2

项与 Theron Pharmaceuticals, Inc. 相关的临床试验

NCT02382510 / Completed临床2期

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics

This multiple ascending dose study is to determine the safety and bronchodilator activity of TRN-157 in 59 mild and moderate asthmatics.

开始日期2015-04-01

申办/合作机构

Theron Pharmaceuticals, Inc.

NCT02133339 / Completed临床1期

A Phase I, Randomized, Double-blind, Placebo Controlled, Single Ascending Dose Study to Evaluate the Safety and Tolerability of Nebulized, TRN-157 Inhalation Solution in Healthy Subjects

This single ascending dose study is to determine and evaluate the safety and tolerability of TRN-157 in approximately 40 healthy subjects.

开始日期2014-05-01

申办/合作机构

Theron Pharmaceuticals, Inc.

100 项与 Theron Pharmaceuticals, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Theron Pharmaceuticals, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Theron Pharmaceuticals, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Theron Pharmaceuticals, Inc. 相关的转化医学

登录后查看更多信息